Public Health Agency of Canada / Agence de santé public du Canada
Skip first menu Skip all menus Français Contact Us Help Search Canada Site
Home Centers & Labs Publications Guidelines A-Z Index
Check the help on Web Accessibility features Child Health Adult Health Seniors Health Surveillance Health Canada
Public Health Agency of Canada

 

 

 

Supplement
Guidelines for the
Prevention and Control
of Invasive Group A
Streptococcal Disease

Volume: 32S2 - October 2006

Full version: PDF Version PDF
26 pages (592 KB)


Supplement Guidelines for the Prevention and Control of Invasive Group A Streptococcal Disease - cover

Table of Contents

  1. Introduction
  2. Objectives
  3. Surveillance of Invasive GAS Disease in Canada
  4. Epidemiology of Invasive GAS Disease in Canada
  5. Definitions
    5.1 National case definition
    5.2 Definitions for public health management
  6. Management of Invasive GAS Disease
    6.1 Case management
    6.2 Contact management.
    6.3 Long-term care facilities
    6.4 Child care centres
  7. Recommendations for Chemoprophylaxis
  8. Vaccines
  9. Communications
    9.1 Communication pertaining to sporadic cases
    9.2 Communication pertaining to clusters or outbreaks
  10. Areas for Future Research

References

Tables:

  1. National Case Definition for Invasive GAS Disease
  2. Definition of Cases
  3. Definition of Close Contacts
  4. Impetus for Action for Organization-based Outbreaks or Clusters
  5. Recommendations for ContactManagement
  6. Recommended Chemoprophylaxis Regimens for Close Contacts

Annexes:

  1. Persons Involved in Guidelines Development and Review
  2. Laboratory Support for Outbreak Investigation of Invasive GAS Disease
  3. Infection Control for Invasive GAS Infection in Hospitals

back to the top

1.0 Introduction

Before the introduction of antimicrobials, morbidity from Streptococcus pyogenes or group A streptococcal (GAS) infection was common. The introduction of penicillin and other antibiotics resulted in a steady decline in the incidence of GAS disease through the 1970s. However, in the 1980s, there was a worldwide resurgence of GAS infection, as well as an apparent increase in virulence1-6.

Because of the severity of invasive GAS disease and the increased risk of infection among close contacts of sporadic cases, these guidelines have been formulated through a consensus process to advise public health officials and clinicians about the public health management of invasive GAS cases and their close contacts. Participants involved in the consensus process are listed in Annex 1.


Full version: PDF Version PDF
26 pages (592 KB)

 

Last Updated: 2006-10-11 Top